Global Dermatology Drugs for Pets Market Research Report 2020
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type, the Dermatology Drugs for Pets market is segmented into
Segment by Application
The Dermatology Drugs for Pets market is analysed and market size information is provided by regions (countries).
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.
The key regions covered in the Dermatology Drugs for Pets market report are:
This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.
The major players in global Dermatology Drugs for Pets market include:
Segment by Type, the Dermatology Drugs for Pets market is segmented into
- Antibiotics
- Antifungal Drugs
- Others
Segment by Application
- Pets Clinics
- Pets Hospitals
- Others
The Dermatology Drugs for Pets market is analysed and market size information is provided by regions (countries).
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.
The key regions covered in the Dermatology Drugs for Pets market report are:
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- Taiwan
- Indonesia
- Thailand
- Malaysia
- Philippines
- Vietnam
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- U.A.E
This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.
The major players in global Dermatology Drugs for Pets market include:
- Bayer Animal Health
- Boehringer Ingelheim Vetmedica
- Ceva Sante Animale
- Zoetis Inc.
- Elanco
- IDEXX Laboratories
- Merial
- Vetoquinol S.A.panies
- Virbac S.A.
1 DERMATOLOGY DRUGS FOR PETS MARKET OVERVIEW
1.1 Product Overview and Scope of Dermatology Drugs for Pets
1.2 Dermatology Drugs for Pets Segment by Type
1.2.1 Global Dermatology Drugs for Pets Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Antibiotics
1.2.3 Antifungal Drugs
1.2.4 Others
1.3 Dermatology Drugs for Pets Segment by Application
1.3.1 Dermatology Drugs for Pets Sales Comparison by Application: 2020 VS 2026
1.3.2 Pets Clinics
1.3.3 Pets Hospitals
1.3.4 Others
1.4 Global Dermatology Drugs for Pets Market Size Estimates and Forecasts
1.4.1 Global Dermatology Drugs for Pets Revenue 2015-2026
1.4.2 Global Dermatology Drugs for Pets Sales 2015-2026
1.4.3 Dermatology Drugs for Pets Market Size by Region: 2020 Versus 2026
1.5 Dermatology Drugs for Pets Industry
1.6 Dermatology Drugs for Pets Market Trends
2 GLOBAL DERMATOLOGY DRUGS FOR PETS MARKET COMPETITION BY MANUFACTURERS
2.1 Global Dermatology Drugs for Pets Sales Market Share by Manufacturers (2015-2020)
2.2 Global Dermatology Drugs for Pets Revenue Share by Manufacturers (2015-2020)
2.3 Global Dermatology Drugs for Pets Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Dermatology Drugs for Pets Manufacturing Sites, Area Served, Product Type
2.5 Dermatology Drugs for Pets Market Competitive Situation and Trends
2.5.1 Dermatology Drugs for Pets Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Dermatology Drugs for Pets Players (Opinion Leaders)
3 DERMATOLOGY DRUGS FOR PETS RETROSPECTIVE MARKET SCENARIO BY REGION
3.1 Global Dermatology Drugs for Pets Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Dermatology Drugs for Pets Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Dermatology Drugs for Pets Market Facts & Figures by Country
3.3.1 North America Dermatology Drugs for Pets Sales by Country
3.3.2 North America Dermatology Drugs for Pets Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Dermatology Drugs for Pets Market Facts & Figures by Country
3.4.1 Europe Dermatology Drugs for Pets Sales by Country
3.4.2 Europe Dermatology Drugs for Pets Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Dermatology Drugs for Pets Market Facts & Figures by Region
3.5.1 Asia Pacific Dermatology Drugs for Pets Sales by Region
3.5.2 Asia Pacific Dermatology Drugs for Pets Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Dermatology Drugs for Pets Market Facts & Figures by Country
3.6.1 Latin America Dermatology Drugs for Pets Sales by Country
3.6.2 Latin America Dermatology Drugs for Pets Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Dermatology Drugs for Pets Market Facts & Figures by Country
3.7.1 Middle East and Africa Dermatology Drugs for Pets Sales by Country
3.7.2 Middle East and Africa Dermatology Drugs for Pets Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 GLOBAL DERMATOLOGY DRUGS FOR PETS HISTORIC MARKET ANALYSIS BY TYPE
4.1 Global Dermatology Drugs for Pets Sales Market Share by Type (2015-2020)
4.2 Global Dermatology Drugs for Pets Revenue Market Share by Type (2015-2020)
4.3 Global Dermatology Drugs for Pets Price Market Share by Type (2015-2020)
4.4 Global Dermatology Drugs for Pets Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 GLOBAL DERMATOLOGY DRUGS FOR PETS HISTORIC MARKET ANALYSIS BY APPLICATION
5.1 Global Dermatology Drugs for Pets Sales Market Share by Application (2015-2020)
5.2 Global Dermatology Drugs for Pets Revenue Market Share by Application (2015-2020)
5.3 Global Dermatology Drugs for Pets Price by Application (2015-2020)
6 COMPANY PROFILES AND KEY FIGURES IN DERMATOLOGY DRUGS FOR PETS BUSINESS
6.1 Bayer Animal Health
6.1.1 Corporation Information
6.1.2 Bayer Animal Health Description, Business Overview and Total Revenue
6.1.3 Bayer Animal Health Dermatology Drugs for Pets Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Bayer Animal Health Products Offered
6.1.5 Bayer Animal Health Recent Development
6.2 Boehringer Ingelheim Vetmedica
6.2.1 Boehringer Ingelheim Vetmedica Corporation Information
6.2.2 Boehringer Ingelheim Vetmedica Description, Business Overview and Total Revenue
6.2.3 Boehringer Ingelheim Vetmedica Dermatology Drugs for Pets Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Boehringer Ingelheim Vetmedica Products Offered
6.2.5 Boehringer Ingelheim Vetmedica Recent Development
6.3 Ceva Sante Animale
6.3.1 Ceva Sante Animale Corporation Information
6.3.2 Ceva Sante Animale Description, Business Overview and Total Revenue
6.3.3 Ceva Sante Animale Dermatology Drugs for Pets Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Ceva Sante Animale Products Offered
6.3.5 Ceva Sante Animale Recent Development
6.4 Zoetis Inc.
6.4.1 Zoetis Inc. Corporation Information
6.4.2 Zoetis Inc. Description, Business Overview and Total Revenue
6.4.3 Zoetis Inc. Dermatology Drugs for Pets Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Zoetis Inc. Products Offered
6.4.5 Zoetis Inc. Recent Development
6.5 Elanco
6.5.1 Elanco Corporation Information
6.5.2 Elanco Description, Business Overview and Total Revenue
6.5.3 Elanco Dermatology Drugs for Pets Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Elanco Products Offered
6.5.5 Elanco Recent Development
6.6 IDEXX Laboratories
6.6.1 IDEXX Laboratories Corporation Information
6.6.2 IDEXX Laboratories Description, Business Overview and Total Revenue
6.6.3 IDEXX Laboratories Dermatology Drugs for Pets Sales, Revenue and Gross Margin (2015-2020)
6.6.4 IDEXX Laboratories Products Offered
6.6.5 IDEXX Laboratories Recent Development
6.7 Merial
6.6.1 Merial Corporation Information
6.6.2 Merial Description, Business Overview and Total Revenue
6.6.3 Merial Dermatology Drugs for Pets Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Merial Products Offered
6.7.5 Merial Recent Development
6.8 Vetoquinol S.A.panies
6.8.1 Vetoquinol S.A.panies Corporation Information
6.8.2 Vetoquinol S.A.panies Description, Business Overview and Total Revenue
6.8.3 Vetoquinol S.A.panies Dermatology Drugs for Pets Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Vetoquinol S.A.panies Products Offered
6.8.5 Vetoquinol S.A.panies Recent Development
6.9 Virbac S.A.
6.9.1 Virbac S.A. Corporation Information
6.9.2 Virbac S.A. Description, Business Overview and Total Revenue
6.9.3 Virbac S.A. Dermatology Drugs for Pets Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Virbac S.A. Products Offered
6.9.5 Virbac S.A. Recent Development
7 DERMATOLOGY DRUGS FOR PETS MANUFACTURING COST ANALYSIS
7.1 Dermatology Drugs for Pets Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Dermatology Drugs for Pets
7.4 Dermatology Drugs for Pets Industrial Chain Analysis
8 MARKETING CHANNEL, DISTRIBUTORS AND CUSTOMERS
8.1 Marketing Channel
8.2 Dermatology Drugs for Pets Distributors List
8.3 Dermatology Drugs for Pets Customers
9 MARKET DYNAMICS
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 GLOBAL MARKET FORECAST
10.1 Global Dermatology Drugs for Pets Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Dermatology Drugs for Pets by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Dermatology Drugs for Pets by Type (2021-2026)
10.2 Dermatology Drugs for Pets Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Dermatology Drugs for Pets by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Dermatology Drugs for Pets by Application (2021-2026)
10.3 Dermatology Drugs for Pets Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Dermatology Drugs for Pets by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Dermatology Drugs for Pets by Region (2021-2026)
10.4 North America Dermatology Drugs for Pets Estimates and Projections (2021-2026)
10.5 Europe Dermatology Drugs for Pets Estimates and Projections (2021-2026)
10.6 Asia Pacific Dermatology Drugs for Pets Estimates and Projections (2021-2026)
10.7 Latin America Dermatology Drugs for Pets Estimates and Projections (2021-2026)
10.8 Middle East and Africa Dermatology Drugs for Pets Estimates and Projections (2021-2026)
11 RESEARCH FINDING AND CONCLUSION
12 METHODOLOGY AND DATA SOURCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
1.1 Product Overview and Scope of Dermatology Drugs for Pets
1.2 Dermatology Drugs for Pets Segment by Type
1.2.1 Global Dermatology Drugs for Pets Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Antibiotics
1.2.3 Antifungal Drugs
1.2.4 Others
1.3 Dermatology Drugs for Pets Segment by Application
1.3.1 Dermatology Drugs for Pets Sales Comparison by Application: 2020 VS 2026
1.3.2 Pets Clinics
1.3.3 Pets Hospitals
1.3.4 Others
1.4 Global Dermatology Drugs for Pets Market Size Estimates and Forecasts
1.4.1 Global Dermatology Drugs for Pets Revenue 2015-2026
1.4.2 Global Dermatology Drugs for Pets Sales 2015-2026
1.4.3 Dermatology Drugs for Pets Market Size by Region: 2020 Versus 2026
1.5 Dermatology Drugs for Pets Industry
1.6 Dermatology Drugs for Pets Market Trends
2 GLOBAL DERMATOLOGY DRUGS FOR PETS MARKET COMPETITION BY MANUFACTURERS
2.1 Global Dermatology Drugs for Pets Sales Market Share by Manufacturers (2015-2020)
2.2 Global Dermatology Drugs for Pets Revenue Share by Manufacturers (2015-2020)
2.3 Global Dermatology Drugs for Pets Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Dermatology Drugs for Pets Manufacturing Sites, Area Served, Product Type
2.5 Dermatology Drugs for Pets Market Competitive Situation and Trends
2.5.1 Dermatology Drugs for Pets Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Dermatology Drugs for Pets Players (Opinion Leaders)
3 DERMATOLOGY DRUGS FOR PETS RETROSPECTIVE MARKET SCENARIO BY REGION
3.1 Global Dermatology Drugs for Pets Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Dermatology Drugs for Pets Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Dermatology Drugs for Pets Market Facts & Figures by Country
3.3.1 North America Dermatology Drugs for Pets Sales by Country
3.3.2 North America Dermatology Drugs for Pets Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Dermatology Drugs for Pets Market Facts & Figures by Country
3.4.1 Europe Dermatology Drugs for Pets Sales by Country
3.4.2 Europe Dermatology Drugs for Pets Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Dermatology Drugs for Pets Market Facts & Figures by Region
3.5.1 Asia Pacific Dermatology Drugs for Pets Sales by Region
3.5.2 Asia Pacific Dermatology Drugs for Pets Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Dermatology Drugs for Pets Market Facts & Figures by Country
3.6.1 Latin America Dermatology Drugs for Pets Sales by Country
3.6.2 Latin America Dermatology Drugs for Pets Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Dermatology Drugs for Pets Market Facts & Figures by Country
3.7.1 Middle East and Africa Dermatology Drugs for Pets Sales by Country
3.7.2 Middle East and Africa Dermatology Drugs for Pets Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 GLOBAL DERMATOLOGY DRUGS FOR PETS HISTORIC MARKET ANALYSIS BY TYPE
4.1 Global Dermatology Drugs for Pets Sales Market Share by Type (2015-2020)
4.2 Global Dermatology Drugs for Pets Revenue Market Share by Type (2015-2020)
4.3 Global Dermatology Drugs for Pets Price Market Share by Type (2015-2020)
4.4 Global Dermatology Drugs for Pets Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 GLOBAL DERMATOLOGY DRUGS FOR PETS HISTORIC MARKET ANALYSIS BY APPLICATION
5.1 Global Dermatology Drugs for Pets Sales Market Share by Application (2015-2020)
5.2 Global Dermatology Drugs for Pets Revenue Market Share by Application (2015-2020)
5.3 Global Dermatology Drugs for Pets Price by Application (2015-2020)
6 COMPANY PROFILES AND KEY FIGURES IN DERMATOLOGY DRUGS FOR PETS BUSINESS
6.1 Bayer Animal Health
6.1.1 Corporation Information
6.1.2 Bayer Animal Health Description, Business Overview and Total Revenue
6.1.3 Bayer Animal Health Dermatology Drugs for Pets Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Bayer Animal Health Products Offered
6.1.5 Bayer Animal Health Recent Development
6.2 Boehringer Ingelheim Vetmedica
6.2.1 Boehringer Ingelheim Vetmedica Corporation Information
6.2.2 Boehringer Ingelheim Vetmedica Description, Business Overview and Total Revenue
6.2.3 Boehringer Ingelheim Vetmedica Dermatology Drugs for Pets Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Boehringer Ingelheim Vetmedica Products Offered
6.2.5 Boehringer Ingelheim Vetmedica Recent Development
6.3 Ceva Sante Animale
6.3.1 Ceva Sante Animale Corporation Information
6.3.2 Ceva Sante Animale Description, Business Overview and Total Revenue
6.3.3 Ceva Sante Animale Dermatology Drugs for Pets Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Ceva Sante Animale Products Offered
6.3.5 Ceva Sante Animale Recent Development
6.4 Zoetis Inc.
6.4.1 Zoetis Inc. Corporation Information
6.4.2 Zoetis Inc. Description, Business Overview and Total Revenue
6.4.3 Zoetis Inc. Dermatology Drugs for Pets Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Zoetis Inc. Products Offered
6.4.5 Zoetis Inc. Recent Development
6.5 Elanco
6.5.1 Elanco Corporation Information
6.5.2 Elanco Description, Business Overview and Total Revenue
6.5.3 Elanco Dermatology Drugs for Pets Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Elanco Products Offered
6.5.5 Elanco Recent Development
6.6 IDEXX Laboratories
6.6.1 IDEXX Laboratories Corporation Information
6.6.2 IDEXX Laboratories Description, Business Overview and Total Revenue
6.6.3 IDEXX Laboratories Dermatology Drugs for Pets Sales, Revenue and Gross Margin (2015-2020)
6.6.4 IDEXX Laboratories Products Offered
6.6.5 IDEXX Laboratories Recent Development
6.7 Merial
6.6.1 Merial Corporation Information
6.6.2 Merial Description, Business Overview and Total Revenue
6.6.3 Merial Dermatology Drugs for Pets Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Merial Products Offered
6.7.5 Merial Recent Development
6.8 Vetoquinol S.A.panies
6.8.1 Vetoquinol S.A.panies Corporation Information
6.8.2 Vetoquinol S.A.panies Description, Business Overview and Total Revenue
6.8.3 Vetoquinol S.A.panies Dermatology Drugs for Pets Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Vetoquinol S.A.panies Products Offered
6.8.5 Vetoquinol S.A.panies Recent Development
6.9 Virbac S.A.
6.9.1 Virbac S.A. Corporation Information
6.9.2 Virbac S.A. Description, Business Overview and Total Revenue
6.9.3 Virbac S.A. Dermatology Drugs for Pets Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Virbac S.A. Products Offered
6.9.5 Virbac S.A. Recent Development
7 DERMATOLOGY DRUGS FOR PETS MANUFACTURING COST ANALYSIS
7.1 Dermatology Drugs for Pets Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Dermatology Drugs for Pets
7.4 Dermatology Drugs for Pets Industrial Chain Analysis
8 MARKETING CHANNEL, DISTRIBUTORS AND CUSTOMERS
8.1 Marketing Channel
8.2 Dermatology Drugs for Pets Distributors List
8.3 Dermatology Drugs for Pets Customers
9 MARKET DYNAMICS
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 GLOBAL MARKET FORECAST
10.1 Global Dermatology Drugs for Pets Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Dermatology Drugs for Pets by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Dermatology Drugs for Pets by Type (2021-2026)
10.2 Dermatology Drugs for Pets Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Dermatology Drugs for Pets by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Dermatology Drugs for Pets by Application (2021-2026)
10.3 Dermatology Drugs for Pets Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Dermatology Drugs for Pets by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Dermatology Drugs for Pets by Region (2021-2026)
10.4 North America Dermatology Drugs for Pets Estimates and Projections (2021-2026)
10.5 Europe Dermatology Drugs for Pets Estimates and Projections (2021-2026)
10.6 Asia Pacific Dermatology Drugs for Pets Estimates and Projections (2021-2026)
10.7 Latin America Dermatology Drugs for Pets Estimates and Projections (2021-2026)
10.8 Middle East and Africa Dermatology Drugs for Pets Estimates and Projections (2021-2026)
11 RESEARCH FINDING AND CONCLUSION
12 METHODOLOGY AND DATA SOURCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
LIST OF TABLES
Table 1. Global Dermatology Drugs for Pets Sales (K Units) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Dermatology Drugs for Pets Sales (K Units) Comparison by Application: 2020 VS 2026
Table 3. Global Dermatology Drugs for Pets Market Size by Type (K Units) (US$ Million) (2020 VS 2026)
Table 4. Global Key Dermatology Drugs for Pets Manufacturers Covered in This Study
Table 5. Global Dermatology Drugs for Pets Sales (K Units) by Manufacturers (2015-2020)
Table 6. Global Dermatology Drugs for Pets Sales Share by Manufacturers (2015-2020)
Table 7. Global Dermatology Drugs for Pets Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Dermatology Drugs for Pets Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Dermatology Drugs for Pets Average Price (US$/Unit) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Dermatology Drugs for Pets Sales Sites and Area Served
Table 11. Manufacturers Dermatology Drugs for Pets Product Types
Table 12. Global Dermatology Drugs for Pets Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Dermatology Drugs for Pets by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dermatology Drugs for Pets as of 2019)
Table 14.Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Dermatology Drugs for Pets Players
Table 16. Global Dermatology Drugs for Pets Sales (K Units) by Region (2015-2020)
Table 17. Global Dermatology Drugs for Pets Sales Market Share by Region (2015-2020)
Table 18. Global Dermatology Drugs for Pets Revenue (Million US$) by Region (2015-2020)
Table 19. Global Dermatology Drugs for Pets Revenue Market Share by Region (2015-2020)
Table 20. North America Dermatology Drugs for Pets Sales by Country (2015-2020) (K Units)
Table 21. North America Dermatology Drugs for Pets Sales Market Share by Country (2015-2020)
Table 22. North America Dermatology Drugs for Pets Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Dermatology Drugs for Pets Revenue Market Share by Country (2015-2020)
Table 24. Europe Dermatology Drugs for Pets Sales by Country (2015-2020) (K Units)
Table 25. Europe Dermatology Drugs for Pets Sales Market Share by Country (2015-2020)
Table 26. Europe Dermatology Drugs for Pets Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Dermatology Drugs for Pets Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Dermatology Drugs for Pets Sales by Region (2015-2020) (K Units)
Table 29. Asia Pacific Dermatology Drugs for Pets Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Dermatology Drugs for Pets Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Dermatology Drugs for Pets Revenue Market Share by Region (2015-2020)
Table 32. Latin America Dermatology Drugs for Pets Sales by Country (2015-2020) (K Units)
Table 33. Latin America Dermatology Drugs for Pets Sales Market Share by Country (2015-2020)
Table 34. Latin America Dermatology Drugs for Pets Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Dermatology Drugs for Pets Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Dermatology Drugs for Pets Sales by Country (2015-2020) (K Units)
Table 37. Middle East and Africa Dermatology Drugs for Pets Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Dermatology Drugs for Pets Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Dermatology Drugs for Pets Revenue Market Share by Country (2015-2020)
Table 40. Global Dermatology Drugs for Pets Sales (K Units) by Type (2015-2020)
Table 41. Global Dermatology Drugs for Pets Sales Share by Type (2015-2020)
Table 42. Global Dermatology Drugs for Pets Revenue (Million US$) by Type (2015-2020)
Table 43. Global Dermatology Drugs for Pets Revenue Share by Type (2015-2020)
Table 44. Global Dermatology Drugs for Pets Price (US$/Unit) by Type (2015-2020)
Table 45. Global Dermatology Drugs for Pets Sales (K Units) by Application (2015-2020)
Table 46. Global Dermatology Drugs for Pets Sales Market Share by Application (2015-2020)
Table 47. Global Dermatology Drugs for Pets Sales Growth Rate by Application (2015-2020)
Table 48. Bayer Animal Health Dermatology Drugs for Pets Corporation Information
Table 49. Bayer Animal Health Description and Business Overview
Table 50. Bayer Animal Health Dermatology Drugs for Pets Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 51. Bayer Animal Health Main Product
Table 52. Bayer Animal Health Recent Development
Table 53. Boehringer Ingelheim Vetmedica Dermatology Drugs for Pets Corporation Information
Table 54. Boehringer Ingelheim Vetmedica Corporation Information
Table 55. Boehringer Ingelheim Vetmedica Dermatology Drugs for Pets Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 56. Boehringer Ingelheim Vetmedica Main Product
Table 57. Boehringer Ingelheim Vetmedica Recent Development
Table 58. Ceva Sante Animale Dermatology Drugs for Pets Corporation Information
Table 59. Ceva Sante Animale Corporation Information
Table 60. Ceva Sante Animale Dermatology Drugs for Pets Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 61. Ceva Sante Animale Main Product
Table 62. Ceva Sante Animale Recent Development
Table 63. Zoetis Inc. Dermatology Drugs for Pets Corporation Information
Table 64. Zoetis Inc. Corporation Information
Table 65. Zoetis Inc. Dermatology Drugs for Pets Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 66. Zoetis Inc. Main Product
Table 67. Zoetis Inc. Recent Development
Table 68. Elanco Dermatology Drugs for Pets Corporation Information
Table 69. Elanco Corporation Information
Table 70. Elanco Dermatology Drugs for Pets Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 71. Elanco Main Product
Table 72. Elanco Recent Development
Table 73. IDEXX Laboratories Dermatology Drugs for Pets Corporation Information
Table 74. IDEXX Laboratories Corporation Information
Table 75. IDEXX Laboratories Dermatology Drugs for Pets Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 76. IDEXX Laboratories Main Product
Table 77. IDEXX Laboratories Recent Development
Table 78. Merial Dermatology Drugs for Pets Corporation Information
Table 79. Merial Corporation Information
Table 80. Merial Dermatology Drugs for Pets Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 81. Merial Main Product
Table 82. Merial Recent Development
Table 83. Vetoquinol S.A.panies Dermatology Drugs for Pets Corporation Information
Table 84. Vetoquinol S.A.panies Corporation Information
Table 85. Vetoquinol S.A.panies Dermatology Drugs for Pets Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 86. Vetoquinol S.A.panies Main Product
Table 87. Vetoquinol S.A.panies Recent Development
Table 88. Virbac S.A. Dermatology Drugs for Pets Corporation Information
Table 89. Virbac S.A. Corporation Information
Table 90. Virbac S.A. Dermatology Drugs for Pets Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 91. Virbac S.A. Main Product
Table 92. Virbac S.A. Recent Development
Table 93. Sales Base and Market Concentration Rate of Raw Material
Table 94. Key Suppliers of Raw Materials
Table 95. Dermatology Drugs for Pets Distributors List
Table 96. Dermatology Drugs for Pets Customers List
Table 97. Market Key Trends
Table 98. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 99. Key Challenges
Table 100. Global Dermatology Drugs for Pets Sales (K Units) Forecast by Type (2021-2026)
Table 101. Global Dermatology Drugs for Pets Sales Market Share Forecast by Type (2021-2026)
Table 102. Global Dermatology Drugs for Pets Revenue (Million US$) Forecast by Type (2021-2026)
Table 103. Global Dermatology Drugs for Pets Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 104. Global Dermatology Drugs for Pets Sales (K Units) Forecast by Application (2021-2026)
Table 105. Global Dermatology Drugs for Pets Revenue (Million US$) Forecast by Application (2021-2026)
Table 106. Global Dermatology Drugs for Pets Sales (K Units) Forecast by Region (2021-2026)
Table 107. Global Dermatology Drugs for Pets Sales Market Share Forecast by Region (2021-2026)
Table 108. Global Dermatology Drugs for Pets Revenue Forecast by Region (2021-2026) (US$ Million)
Table 109. Global Dermatology Drugs for Pets Revenue Market Share Forecast by Region (2021-2026)
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
Table 1. Global Dermatology Drugs for Pets Sales (K Units) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Dermatology Drugs for Pets Sales (K Units) Comparison by Application: 2020 VS 2026
Table 3. Global Dermatology Drugs for Pets Market Size by Type (K Units) (US$ Million) (2020 VS 2026)
Table 4. Global Key Dermatology Drugs for Pets Manufacturers Covered in This Study
Table 5. Global Dermatology Drugs for Pets Sales (K Units) by Manufacturers (2015-2020)
Table 6. Global Dermatology Drugs for Pets Sales Share by Manufacturers (2015-2020)
Table 7. Global Dermatology Drugs for Pets Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Dermatology Drugs for Pets Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Dermatology Drugs for Pets Average Price (US$/Unit) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Dermatology Drugs for Pets Sales Sites and Area Served
Table 11. Manufacturers Dermatology Drugs for Pets Product Types
Table 12. Global Dermatology Drugs for Pets Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Dermatology Drugs for Pets by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dermatology Drugs for Pets as of 2019)
Table 14.Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Dermatology Drugs for Pets Players
Table 16. Global Dermatology Drugs for Pets Sales (K Units) by Region (2015-2020)
Table 17. Global Dermatology Drugs for Pets Sales Market Share by Region (2015-2020)
Table 18. Global Dermatology Drugs for Pets Revenue (Million US$) by Region (2015-2020)
Table 19. Global Dermatology Drugs for Pets Revenue Market Share by Region (2015-2020)
Table 20. North America Dermatology Drugs for Pets Sales by Country (2015-2020) (K Units)
Table 21. North America Dermatology Drugs for Pets Sales Market Share by Country (2015-2020)
Table 22. North America Dermatology Drugs for Pets Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Dermatology Drugs for Pets Revenue Market Share by Country (2015-2020)
Table 24. Europe Dermatology Drugs for Pets Sales by Country (2015-2020) (K Units)
Table 25. Europe Dermatology Drugs for Pets Sales Market Share by Country (2015-2020)
Table 26. Europe Dermatology Drugs for Pets Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Dermatology Drugs for Pets Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Dermatology Drugs for Pets Sales by Region (2015-2020) (K Units)
Table 29. Asia Pacific Dermatology Drugs for Pets Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Dermatology Drugs for Pets Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Dermatology Drugs for Pets Revenue Market Share by Region (2015-2020)
Table 32. Latin America Dermatology Drugs for Pets Sales by Country (2015-2020) (K Units)
Table 33. Latin America Dermatology Drugs for Pets Sales Market Share by Country (2015-2020)
Table 34. Latin America Dermatology Drugs for Pets Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Dermatology Drugs for Pets Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Dermatology Drugs for Pets Sales by Country (2015-2020) (K Units)
Table 37. Middle East and Africa Dermatology Drugs for Pets Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Dermatology Drugs for Pets Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Dermatology Drugs for Pets Revenue Market Share by Country (2015-2020)
Table 40. Global Dermatology Drugs for Pets Sales (K Units) by Type (2015-2020)
Table 41. Global Dermatology Drugs for Pets Sales Share by Type (2015-2020)
Table 42. Global Dermatology Drugs for Pets Revenue (Million US$) by Type (2015-2020)
Table 43. Global Dermatology Drugs for Pets Revenue Share by Type (2015-2020)
Table 44. Global Dermatology Drugs for Pets Price (US$/Unit) by Type (2015-2020)
Table 45. Global Dermatology Drugs for Pets Sales (K Units) by Application (2015-2020)
Table 46. Global Dermatology Drugs for Pets Sales Market Share by Application (2015-2020)
Table 47. Global Dermatology Drugs for Pets Sales Growth Rate by Application (2015-2020)
Table 48. Bayer Animal Health Dermatology Drugs for Pets Corporation Information
Table 49. Bayer Animal Health Description and Business Overview
Table 50. Bayer Animal Health Dermatology Drugs for Pets Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 51. Bayer Animal Health Main Product
Table 52. Bayer Animal Health Recent Development
Table 53. Boehringer Ingelheim Vetmedica Dermatology Drugs for Pets Corporation Information
Table 54. Boehringer Ingelheim Vetmedica Corporation Information
Table 55. Boehringer Ingelheim Vetmedica Dermatology Drugs for Pets Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 56. Boehringer Ingelheim Vetmedica Main Product
Table 57. Boehringer Ingelheim Vetmedica Recent Development
Table 58. Ceva Sante Animale Dermatology Drugs for Pets Corporation Information
Table 59. Ceva Sante Animale Corporation Information
Table 60. Ceva Sante Animale Dermatology Drugs for Pets Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 61. Ceva Sante Animale Main Product
Table 62. Ceva Sante Animale Recent Development
Table 63. Zoetis Inc. Dermatology Drugs for Pets Corporation Information
Table 64. Zoetis Inc. Corporation Information
Table 65. Zoetis Inc. Dermatology Drugs for Pets Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 66. Zoetis Inc. Main Product
Table 67. Zoetis Inc. Recent Development
Table 68. Elanco Dermatology Drugs for Pets Corporation Information
Table 69. Elanco Corporation Information
Table 70. Elanco Dermatology Drugs for Pets Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 71. Elanco Main Product
Table 72. Elanco Recent Development
Table 73. IDEXX Laboratories Dermatology Drugs for Pets Corporation Information
Table 74. IDEXX Laboratories Corporation Information
Table 75. IDEXX Laboratories Dermatology Drugs for Pets Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 76. IDEXX Laboratories Main Product
Table 77. IDEXX Laboratories Recent Development
Table 78. Merial Dermatology Drugs for Pets Corporation Information
Table 79. Merial Corporation Information
Table 80. Merial Dermatology Drugs for Pets Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 81. Merial Main Product
Table 82. Merial Recent Development
Table 83. Vetoquinol S.A.panies Dermatology Drugs for Pets Corporation Information
Table 84. Vetoquinol S.A.panies Corporation Information
Table 85. Vetoquinol S.A.panies Dermatology Drugs for Pets Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 86. Vetoquinol S.A.panies Main Product
Table 87. Vetoquinol S.A.panies Recent Development
Table 88. Virbac S.A. Dermatology Drugs for Pets Corporation Information
Table 89. Virbac S.A. Corporation Information
Table 90. Virbac S.A. Dermatology Drugs for Pets Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 91. Virbac S.A. Main Product
Table 92. Virbac S.A. Recent Development
Table 93. Sales Base and Market Concentration Rate of Raw Material
Table 94. Key Suppliers of Raw Materials
Table 95. Dermatology Drugs for Pets Distributors List
Table 96. Dermatology Drugs for Pets Customers List
Table 97. Market Key Trends
Table 98. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 99. Key Challenges
Table 100. Global Dermatology Drugs for Pets Sales (K Units) Forecast by Type (2021-2026)
Table 101. Global Dermatology Drugs for Pets Sales Market Share Forecast by Type (2021-2026)
Table 102. Global Dermatology Drugs for Pets Revenue (Million US$) Forecast by Type (2021-2026)
Table 103. Global Dermatology Drugs for Pets Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 104. Global Dermatology Drugs for Pets Sales (K Units) Forecast by Application (2021-2026)
Table 105. Global Dermatology Drugs for Pets Revenue (Million US$) Forecast by Application (2021-2026)
Table 106. Global Dermatology Drugs for Pets Sales (K Units) Forecast by Region (2021-2026)
Table 107. Global Dermatology Drugs for Pets Sales Market Share Forecast by Region (2021-2026)
Table 108. Global Dermatology Drugs for Pets Revenue Forecast by Region (2021-2026) (US$ Million)
Table 109. Global Dermatology Drugs for Pets Revenue Market Share Forecast by Region (2021-2026)
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Picture of Dermatology Drugs for Pets
Figure 2. Global Dermatology Drugs for Pets Sales Market Share by Type: 2020 VS 2026
Figure 3. Antibiotics Product Picture
Figure 4. Antifungal Drugs Product Picture
Figure 5. Others Product Picture
Figure 6. Global Dermatology Drugs for Pets Consumption Market Share by Application: 2020 VS 2026
Figure 7. Pets Clinics
Figure 8. Pets Hospitals
Figure 9. Others
Figure 10. Global Dermatology Drugs for Pets Market Size 2015-2026 (US$ Million)
Figure 11. Global Dermatology Drugs for Pets Sales Capacity (K Units) (2015-2026)
Figure 12. Global Dermatology Drugs for Pets Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Dermatology Drugs for Pets Sales Share by Manufacturers in 2020
Figure 14. Global Dermatology Drugs for Pets Revenue Share by Manufacturers in 2019
Figure 15. The Global 5 and 10 Largest Players: Market Share by Dermatology Drugs for Pets Revenue in 2019
Figure 16. Dermatology Drugs for Pets Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 17. Global Dermatology Drugs for Pets Sales Market Share by Region (2015-2020)
Figure 18. Global Dermatology Drugs for Pets Sales Market Share by Region in 2019
Figure 19. Global Dermatology Drugs for Pets Revenue Market Share by Region (2015-2020)
Figure 20. Global Dermatology Drugs for Pets Revenue Market Share by Region in 2019
Figure 21. North America Dermatology Drugs for Pets Sales Market Share by Country in 2019
Figure 22. North America Dermatology Drugs for Pets Revenue Market Share by Country in 2019
Figure 23. U.S. Dermatology Drugs for Pets Sales Growth Rate (2015-2020) (K Units)
Figure 24. U.S. Dermatology Drugs for Pets Revenue Growth Rate (2015-2020) (US$ Million)
Figure 25. Canada Dermatology Drugs for Pets Sales Growth Rate (2015-2020) (K Units)
Figure 26. Canada Dermatology Drugs for Pets Revenue Growth Rate (2015-2020) (US$ Million)
Figure 27. Europe Dermatology Drugs for Pets Sales Market Share by Country in 2019
Figure 28. Europe Dermatology Drugs for Pets Revenue Market Share by Country in 2019
Figure 29. Germany Dermatology Drugs for Pets Sales Growth Rate (2015-2020) (K Units)
Figure 30. Germany Dermatology Drugs for Pets Revenue Growth Rate (2015-2020) (US$ Million)
Figure 31. France Dermatology Drugs for Pets Sales Growth Rate (2015-2020) (K Units)
Figure 32. France Dermatology Drugs for Pets Revenue Growth Rate (2015-2020) (US$ Million)
Figure 33. U.K. Dermatology Drugs for Pets Sales Growth Rate (2015-2020) (K Units)
Figure 34. U.K. Dermatology Drugs for Pets Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Italy Dermatology Drugs for Pets Sales Growth Rate (2015-2020) (K Units)
Figure 36. Italy Dermatology Drugs for Pets Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Russia Dermatology Drugs for Pets Sales Growth Rate (2015-2020) (K Units)
Figure 38. Russia Dermatology Drugs for Pets Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Asia Pacific Dermatology Drugs for Pets Sales Market Share by Region in 2019
Figure 40. Asia Pacific Dermatology Drugs for Pets Revenue Market Share by Region in 2019
Figure 41. China Dermatology Drugs for Pets Sales Growth Rate (2015-2020) (K Units)
Figure 42. China Dermatology Drugs for Pets Revenue Growth Rate (2015-2020) (US$ Million)
Figure 43. Japan Dermatology Drugs for Pets Sales Growth Rate (2015-2020) (K Units)
Figure 44. Japan Dermatology Drugs for Pets Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. South Korea Dermatology Drugs for Pets Sales Growth Rate (2015-2020) (K Units)
Figure 46. South Korea Dermatology Drugs for Pets Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. India Dermatology Drugs for Pets Sales Growth Rate (2015-2020) (K Units)
Figure 48. India Dermatology Drugs for Pets Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Australia Dermatology Drugs for Pets Sales Growth Rate (2015-2020) (K Units)
Figure 50. Australia Dermatology Drugs for Pets Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Taiwan Dermatology Drugs for Pets Sales Growth Rate (2015-2020) (K Units)
Figure 52. Taiwan Dermatology Drugs for Pets Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Indonesia Dermatology Drugs for Pets Sales Growth Rate (2015-2020) (K Units)
Figure 54. Indonesia Dermatology Drugs for Pets Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Thailand Dermatology Drugs for Pets Sales Growth Rate (2015-2020) (K Units)
Figure 56. Thailand Dermatology Drugs for Pets Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Malaysia Dermatology Drugs for Pets Sales Growth Rate (2015-2020) (K Units)
Figure 58. Malaysia Dermatology Drugs for Pets Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Philippines Dermatology Drugs for Pets Sales Growth Rate (2015-2020) (K Units)
Figure 60. Philippines Dermatology Drugs for Pets Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Vietnam Dermatology Drugs for Pets Sales Growth Rate (2015-2020) (K Units)
Figure 62. Vietnam Dermatology Drugs for Pets Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Latin America Dermatology Drugs for Pets Sales Market Share by Country in 2019
Figure 64. Latin America Dermatology Drugs for Pets Revenue Market Share by Country in 2019
Figure 65. Mexico Dermatology Drugs for Pets Sales Growth Rate (2015-2020) (K Units)
Figure 66. Mexico Dermatology Drugs for Pets Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Brazil Dermatology Drugs for Pets Sales Growth Rate (2015-2020) (K Units)
Figure 68. Brazil Dermatology Drugs for Pets Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Argentina Dermatology Drugs for Pets Sales Growth Rate (2015-2020) (K Units)
Figure 70. Argentina Dermatology Drugs for Pets Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Middle East and Africa Dermatology Drugs for Pets Sales Market Share by Country in 2019
Figure 72. Middle East and Africa Dermatology Drugs for Pets Revenue Market Share by Country in 2019
Figure 73. Turkey Dermatology Drugs for Pets Sales Growth Rate (2015-2020) (K Units)
Figure 74. Turkey Dermatology Drugs for Pets Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Saudi Arabia Dermatology Drugs for Pets Sales Growth Rate (2015-2020) (K Units)
Figure 76. Saudi Arabia Dermatology Drugs for Pets Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. U.A.E Dermatology Drugs for Pets Sales Growth Rate (2015-2020) (K Units)
Figure 78. U.A.E Dermatology Drugs for Pets Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Sales Market Share of Dermatology Drugs for Pets by Type (2015-2020)
Figure 80. Sales Market Share of Dermatology Drugs for Pets by Type in 2019
Figure 81. Revenue Share of Dermatology Drugs for Pets by Type (2015-2020)
Figure 82. Revenue Market Share of Dermatology Drugs for Pets by Type in 2019
Figure 83. Global Dermatology Drugs for Pets Sales Growth by Type (2015-2020) (K Units)
Figure 84. Global Dermatology Drugs for Pets Sales Market Share by Application (2015-2020)
Figure 85. Global Dermatology Drugs for Pets Sales Market Share by Application in 2019
Figure 86. Global Revenue Share of Dermatology Drugs for Pets by Application (2015-2020)
Figure 87. Global Revenue Share of Dermatology Drugs for Pets by Application in 2020
Figure 88. Bayer Animal Health Total Revenue (US$ Million): 2019 Compared with 2018
Figure 89. Boehringer Ingelheim Vetmedica Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Ceva Sante Animale Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. Zoetis Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. Elanco Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. IDEXX Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. Merial Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. Vetoquinol S.A.panies Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. Virbac S.A. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 97. Price Trend of Key Raw Materials
Figure 98. Manufacturing Cost Structure of Dermatology Drugs for Pets
Figure 99. Manufacturing Process Analysis of Dermatology Drugs for Pets
Figure 100. Dermatology Drugs for Pets Industrial Chain Analysis
Figure 101. Channels of Distribution
Figure 102. Distributors Profiles
Figure 103. Porter's Five Forces Analysis
Figure 104. North America Dermatology Drugs for Pets Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 105. North America Dermatology Drugs for Pets Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 106. Europe Dermatology Drugs for Pets Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 107. Europe Dermatology Drugs for Pets Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 108. Latin America Dermatology Drugs for Pets Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 109. Latin America Dermatology Drugs for Pets Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 110. Middle East and Africa Dermatology Drugs for Pets Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 111. Middle East and Africa Dermatology Drugs for Pets Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 112. Asia Pacific Dermatology Drugs for Pets Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 113. Asia Pacific Dermatology Drugs for Pets Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 114. Bottom-up and Top-down Approaches for This Report
Figure 115. Data Triangulation
Figure 116. Key Executives Interviewed
Figure 1. Picture of Dermatology Drugs for Pets
Figure 2. Global Dermatology Drugs for Pets Sales Market Share by Type: 2020 VS 2026
Figure 3. Antibiotics Product Picture
Figure 4. Antifungal Drugs Product Picture
Figure 5. Others Product Picture
Figure 6. Global Dermatology Drugs for Pets Consumption Market Share by Application: 2020 VS 2026
Figure 7. Pets Clinics
Figure 8. Pets Hospitals
Figure 9. Others
Figure 10. Global Dermatology Drugs for Pets Market Size 2015-2026 (US$ Million)
Figure 11. Global Dermatology Drugs for Pets Sales Capacity (K Units) (2015-2026)
Figure 12. Global Dermatology Drugs for Pets Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Dermatology Drugs for Pets Sales Share by Manufacturers in 2020
Figure 14. Global Dermatology Drugs for Pets Revenue Share by Manufacturers in 2019
Figure 15. The Global 5 and 10 Largest Players: Market Share by Dermatology Drugs for Pets Revenue in 2019
Figure 16. Dermatology Drugs for Pets Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 17. Global Dermatology Drugs for Pets Sales Market Share by Region (2015-2020)
Figure 18. Global Dermatology Drugs for Pets Sales Market Share by Region in 2019
Figure 19. Global Dermatology Drugs for Pets Revenue Market Share by Region (2015-2020)
Figure 20. Global Dermatology Drugs for Pets Revenue Market Share by Region in 2019
Figure 21. North America Dermatology Drugs for Pets Sales Market Share by Country in 2019
Figure 22. North America Dermatology Drugs for Pets Revenue Market Share by Country in 2019
Figure 23. U.S. Dermatology Drugs for Pets Sales Growth Rate (2015-2020) (K Units)
Figure 24. U.S. Dermatology Drugs for Pets Revenue Growth Rate (2015-2020) (US$ Million)
Figure 25. Canada Dermatology Drugs for Pets Sales Growth Rate (2015-2020) (K Units)
Figure 26. Canada Dermatology Drugs for Pets Revenue Growth Rate (2015-2020) (US$ Million)
Figure 27. Europe Dermatology Drugs for Pets Sales Market Share by Country in 2019
Figure 28. Europe Dermatology Drugs for Pets Revenue Market Share by Country in 2019
Figure 29. Germany Dermatology Drugs for Pets Sales Growth Rate (2015-2020) (K Units)
Figure 30. Germany Dermatology Drugs for Pets Revenue Growth Rate (2015-2020) (US$ Million)
Figure 31. France Dermatology Drugs for Pets Sales Growth Rate (2015-2020) (K Units)
Figure 32. France Dermatology Drugs for Pets Revenue Growth Rate (2015-2020) (US$ Million)
Figure 33. U.K. Dermatology Drugs for Pets Sales Growth Rate (2015-2020) (K Units)
Figure 34. U.K. Dermatology Drugs for Pets Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Italy Dermatology Drugs for Pets Sales Growth Rate (2015-2020) (K Units)
Figure 36. Italy Dermatology Drugs for Pets Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Russia Dermatology Drugs for Pets Sales Growth Rate (2015-2020) (K Units)
Figure 38. Russia Dermatology Drugs for Pets Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Asia Pacific Dermatology Drugs for Pets Sales Market Share by Region in 2019
Figure 40. Asia Pacific Dermatology Drugs for Pets Revenue Market Share by Region in 2019
Figure 41. China Dermatology Drugs for Pets Sales Growth Rate (2015-2020) (K Units)
Figure 42. China Dermatology Drugs for Pets Revenue Growth Rate (2015-2020) (US$ Million)
Figure 43. Japan Dermatology Drugs for Pets Sales Growth Rate (2015-2020) (K Units)
Figure 44. Japan Dermatology Drugs for Pets Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. South Korea Dermatology Drugs for Pets Sales Growth Rate (2015-2020) (K Units)
Figure 46. South Korea Dermatology Drugs for Pets Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. India Dermatology Drugs for Pets Sales Growth Rate (2015-2020) (K Units)
Figure 48. India Dermatology Drugs for Pets Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Australia Dermatology Drugs for Pets Sales Growth Rate (2015-2020) (K Units)
Figure 50. Australia Dermatology Drugs for Pets Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Taiwan Dermatology Drugs for Pets Sales Growth Rate (2015-2020) (K Units)
Figure 52. Taiwan Dermatology Drugs for Pets Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Indonesia Dermatology Drugs for Pets Sales Growth Rate (2015-2020) (K Units)
Figure 54. Indonesia Dermatology Drugs for Pets Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Thailand Dermatology Drugs for Pets Sales Growth Rate (2015-2020) (K Units)
Figure 56. Thailand Dermatology Drugs for Pets Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Malaysia Dermatology Drugs for Pets Sales Growth Rate (2015-2020) (K Units)
Figure 58. Malaysia Dermatology Drugs for Pets Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Philippines Dermatology Drugs for Pets Sales Growth Rate (2015-2020) (K Units)
Figure 60. Philippines Dermatology Drugs for Pets Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Vietnam Dermatology Drugs for Pets Sales Growth Rate (2015-2020) (K Units)
Figure 62. Vietnam Dermatology Drugs for Pets Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Latin America Dermatology Drugs for Pets Sales Market Share by Country in 2019
Figure 64. Latin America Dermatology Drugs for Pets Revenue Market Share by Country in 2019
Figure 65. Mexico Dermatology Drugs for Pets Sales Growth Rate (2015-2020) (K Units)
Figure 66. Mexico Dermatology Drugs for Pets Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Brazil Dermatology Drugs for Pets Sales Growth Rate (2015-2020) (K Units)
Figure 68. Brazil Dermatology Drugs for Pets Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Argentina Dermatology Drugs for Pets Sales Growth Rate (2015-2020) (K Units)
Figure 70. Argentina Dermatology Drugs for Pets Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Middle East and Africa Dermatology Drugs for Pets Sales Market Share by Country in 2019
Figure 72. Middle East and Africa Dermatology Drugs for Pets Revenue Market Share by Country in 2019
Figure 73. Turkey Dermatology Drugs for Pets Sales Growth Rate (2015-2020) (K Units)
Figure 74. Turkey Dermatology Drugs for Pets Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Saudi Arabia Dermatology Drugs for Pets Sales Growth Rate (2015-2020) (K Units)
Figure 76. Saudi Arabia Dermatology Drugs for Pets Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. U.A.E Dermatology Drugs for Pets Sales Growth Rate (2015-2020) (K Units)
Figure 78. U.A.E Dermatology Drugs for Pets Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Sales Market Share of Dermatology Drugs for Pets by Type (2015-2020)
Figure 80. Sales Market Share of Dermatology Drugs for Pets by Type in 2019
Figure 81. Revenue Share of Dermatology Drugs for Pets by Type (2015-2020)
Figure 82. Revenue Market Share of Dermatology Drugs for Pets by Type in 2019
Figure 83. Global Dermatology Drugs for Pets Sales Growth by Type (2015-2020) (K Units)
Figure 84. Global Dermatology Drugs for Pets Sales Market Share by Application (2015-2020)
Figure 85. Global Dermatology Drugs for Pets Sales Market Share by Application in 2019
Figure 86. Global Revenue Share of Dermatology Drugs for Pets by Application (2015-2020)
Figure 87. Global Revenue Share of Dermatology Drugs for Pets by Application in 2020
Figure 88. Bayer Animal Health Total Revenue (US$ Million): 2019 Compared with 2018
Figure 89. Boehringer Ingelheim Vetmedica Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Ceva Sante Animale Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. Zoetis Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. Elanco Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. IDEXX Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. Merial Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. Vetoquinol S.A.panies Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. Virbac S.A. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 97. Price Trend of Key Raw Materials
Figure 98. Manufacturing Cost Structure of Dermatology Drugs for Pets
Figure 99. Manufacturing Process Analysis of Dermatology Drugs for Pets
Figure 100. Dermatology Drugs for Pets Industrial Chain Analysis
Figure 101. Channels of Distribution
Figure 102. Distributors Profiles
Figure 103. Porter's Five Forces Analysis
Figure 104. North America Dermatology Drugs for Pets Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 105. North America Dermatology Drugs for Pets Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 106. Europe Dermatology Drugs for Pets Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 107. Europe Dermatology Drugs for Pets Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 108. Latin America Dermatology Drugs for Pets Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 109. Latin America Dermatology Drugs for Pets Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 110. Middle East and Africa Dermatology Drugs for Pets Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 111. Middle East and Africa Dermatology Drugs for Pets Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 112. Asia Pacific Dermatology Drugs for Pets Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 113. Asia Pacific Dermatology Drugs for Pets Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 114. Bottom-up and Top-down Approaches for This Report
Figure 115. Data Triangulation
Figure 116. Key Executives Interviewed
